Clinical Trial Update: SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST [Phase 2]

View source ↗

Summary

Update on the SARC044 Phase II trial evaluating the combination of bezuclastinib and sunitinib in patients with gastrointestinal stromal tumors. The trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Bezuclastinib (bezuclastinib)
• Sunitinib (sunitinib)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Gastrointestinal Stromal Tumors, GIST | Phase 2 | Status: ACTIVE_NOT_RECRUITING